BridgeMD
New treatment option for Stroke
Official title Task-Oriented Upper Limb Training With Focal Vibration in Stroke
ClinicalTrials.gov ID: NCT07558876
What this study is testing
- What it's testing
- This study aims to investigate the effects of task-oriented upper limb training combined with focal vibration on hand function, proprioception, and muscle tone in patients with stroke. Participants will be randomly assigned to either an experimental group receiving task-oriented training with concurrent focal vibration or a control group receiving task-oriented training alone.
- Time commitment: about 6 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 and older
You may be able to join if
- Individuals diagnosed with stroke at least 3 months prior
- Individuals with sufficient cognitive function (Mini-Mental State Examination [MMSE] score ≥ 24)
- Individuals able to maintain a seated position independently and perform upper limb functional tasks (Trunk Control Test [TCT] ≥ 50)
- Individuals with muscle tone of the affected upper limb of Modified Ashworth Scale (MAS) Grade ≤ 2
- Individuals with Fugl-Meyer Assessment-Upper Extremity (FMA-UE) scores between 20 and 50
You likely can't join if
- Individuals within 3 months after stroke onset
- Individuals with fractures, severe soft tissue injuries, or contraindications to focal vibration
- Individuals with severe sensory hypersensitivity or complex regional pain syndrome (CRPS)
- Individuals who received treatments affecting upper limb function within the past 3 months (e.g., botulinum toxin injection, surgery, nerve block)
See the full eligibility criteria
- Individuals diagnosed with stroke at least 3 months prior
- Individuals with sufficient cognitive function (Mini-Mental State Examination [MMSE] score ≥ 24)
- Individuals able to maintain a seated position independently and perform upper limb functional tasks (Trunk Control Test [TCT] ≥ 50)
- Individuals with muscle tone of the affected upper limb of Modified Ashworth Scale (MAS) Grade ≤ 2
- Individuals with Fugl-Meyer Assessment-Upper Extremity (FMA-UE) scores between 20 and 50
- Individuals able to grasp and move objects with the affected upper limb and with muscle strength of Manual Muscle Test (MMT) Grade ≥ 3
- Individuals with impaired proprioception in the affected hand (defined as a score \< 2 on the wrist or thumb position item of the FMA-UE)
- Individuals within 3 months after stroke onset
- Individuals with fractures, severe soft tissue injuries, or contraindications to focal vibration
- Individuals with severe sensory hypersensitivity or complex regional pain syndrome (CRPS)
- Individuals who received treatments affecting upper limb function within the past 3 months (e.g., botulinum toxin injection, surgery, nerve block)
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 6 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.